Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 36 of 114

  1. Daunorubicin/Idarubicin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML, Adult

    phase 3 small molecule active

    1 trial

  2. Dazodalibep

    Amgen

    Sjögren’s Syndrome

    phase 3 small molecule active

    1 trial

  3. De-escalation to ticagrelor 60 mg at day 30

    COLLEGIUM PHARMACEUTICAL, INC

    Non ST Segment Elevation Acute Coronary Syndrome

    phase 3 small molecule active

    1 trial

  4. Debamestrocel - MSC-NTF (NurOwn)

    BRAINSTORM CELL THERAPEUTICS INC.

    Amyotrophic Lateral Sclerosis (ALS)

    phase 3 mab active

    1 trial

  5. Debio 4126-301

    Alphapharm Pty Ltd

    Acromegaly

    phase 3 small molecule active

    1 trial

  6. Decartes-08

    Cartesian Therapeutics

    Myasthaenia Gravis

    phase 3 mab active

    1 trial

  7. Decitabine

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia, Adult

    phase 3 small molecule active

    1 trial

  8. Decitabine

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  9. Decitabine

    The First People's Hospital of Lianyungang

    Thrombocytopenia

    phase 3 small molecule completed

    1 trial

  10. Decitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myelodysplastic Syndrome

    phase 3 small molecule completed

    1 trial

  11. Decitabine plus HAAG regimen

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  12. Deferasirox

    Novartis Pharmaceuticals

    Transfusion-dependent Iron Overload

    phase 3 small molecule completed

    1 trial

  13. Deferiprone oral solution

    BRIGHT MINDS BIOSCIENCES INC.

    Pantothenate Kinase-Associated Neurodegeneration

    phase 3 small molecule completed

    1 trial

  14. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Hepatic Veno-Occlusive Disease

    phase 3 small molecule completed

    2 trials

  15. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Veno-occlusive Disease

    phase 3 small molecule completed

    2 trials

  16. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Severe Hepatic Veno-Occlusive Disease

    phase 3 small molecule completed

    1 trial

  17. Deflazacort

    PTC THERAPEUTICS, INC.

    Duchenne Muscular Dystrophy

    phase 3 small molecule completed

    3 trials

  18. Deflazacort

    PTC THERAPEUTICS, INC.

    Limb-Girdle Muscular Dystrophy

    phase 3 small molecule terminated

    1 trial

  19. Delamanid + OBR

    Otsuka Beijing Research Institute

    Multidrug-resistant Tuberculosis

    phase 3 small molecule completed

    1 trial

  20. Delandistrogene moxeparvovec-rokl

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    phase 3 small molecule active

    1 trial

  21. Delayed and extended release mesalazine

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  22. Dendritic cell immunotherapy

    NORTHWEST BIOTHERAPEUTICS INC

    Glioblastoma Multiforme

    phase 3 small molecule active

    1 trial

  23. Dendritic cell immunotherapy

    NORTHWEST BIOTHERAPEUTICS INC

    Prostate Cancer

    phase 3 small molecule terminated

    1 trial

  24. Denifanstat

    Sagimet Biosciences

    MASH

    phase 3 small molecule terminated

    1 trial

  25. Denosumab

    Amgen

    Cancer

    phase 3 small molecule completed

    1 trial

  26. Depot naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Addiction

    phase 3 small molecule completed

    1 trial

  27. Deramiocel (CAP-1002)

    CAPRICOR THERAPEUTICS, INC.

    Muscular Dystrophies

    phase 3 mab active

    1 trial

  28. Descovy or Truvada

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule completed

    1 trial

  29. Desmopressin

    Ferring Pharmaceuticals

    Nocturia

    phase 3 small molecule completed

    1 trial

  30. Deucravacitinib

    Bristol-Myers Squibb

    Sjögren's Syndrome

    phase 3 small molecule active

    1 trial

  31. Deutetrabenazine

    Teva Pharma GmbH

    Huntington Disease

    phase 3 small molecule active

    1 trial

  32. Dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Respiratory Distress Syndrome (ARDS)

    phase 3 small molecule active

    1 trial

  33. Dexamethasone

    Amgen

    Relapsed Multiple Myeloma

    phase 3 small molecule completed

    1 trial

  34. Dexamethasone

    Quince Therapeutics

    Crohn's Disease

    phase 3 small molecule terminated

    1 trial

  35. Dexamethasone

    United Therapeutics Europe Ltd

    Shoulder Pain

    phase 3 small molecule terminated

    1 trial

  36. Dexamethasone sodium phosphate

    Quince Therapeutics

    Ataxia Telangiectasia

    phase 3 small molecule completed

    2 trials

  37. Dexamethasone sodium phosphate for encapsulation into autoerythrocytes

    Quince Therapeutics

    Ataxia Telangiectasia (A-T)

    phase 3 small molecule active

    1 trial

  38. Dexlansoprazole

    Takeda

    Gastroesophageal Reflux

    phase 3 small molecule completed

    2 trials

  39. Dexlansoprazole

    Takeda

    Erosive Esophagitis

    phase 3 small molecule terminated

    2 trials

  40. Dexlansoprazole

    Takeda

    Heartburn

    phase 3 small molecule completed

    1 trial

  41. Dexlansoprazole MR

    Takeda

    Gastroesophageal Reflux Disease

    phase 3 small molecule completed

    4 trials

  42. Dexlansoprazole MR

    Takeda

    Esophagitis, Reflux

    phase 3 small molecule completed

    5 trials

  43. Dexlansoprazole MR QD

    Takeda

    Gastroesophageal Reflux

    phase 3 small molecule completed

    1 trial

  44. Dexmedetomidine Hcl 100 Mcg/mL Inj

    Hospital Authority, Hong Kong

    Congenital Heart Disease in Children

    phase 3 small molecule completed

    1 trial

  45. Diclofenac Sodium Topical Gel, 1%

    Amneal Pharma Europe Ltd

    Osteoarthritis

    phase 3 small molecule completed

    1 trial

  46. Diclofenac sodium

    Teva Pharma GmbH

    Actinic Keratosis

    phase 3 small molecule completed

    1 trial

  47. Dienogest

    Hospital Authority, Hong Kong

    Endometriosis

    phase 3 small molecule active

    1 trial

  48. Dinutuximab

    United Therapeutics Europe Ltd

    Small Cell Lung Cancer

    phase 3 mab completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.